Those afflicted with sickle cell disease face many challenges and acute complications. This biopharma company is the leader in treatment of the disease and just reported its fifth straight increase...

To read the full story on AllPennyStocks.com, click here.

Emmaus Life Sciences (NASDAQ:EMMA)
過去 株価チャート
から 4 2024 まで 5 2024 Emmaus Life Sciencesのチャートをもっと見るにはこちらをクリック
Emmaus Life Sciences (NASDAQ:EMMA)
過去 株価チャート
から 5 2023 まで 5 2024 Emmaus Life Sciencesのチャートをもっと見るにはこちらをクリック